Davis Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Davis Capital Management's LLY Position: Q2 2026 in Review
Davis Capital Management increased its Eli Lilly (LLY) stake by 369% in Q2 2026, buying an estimated $49K and bringing the position to 61 shares worth $73.2K. The position accounts for 0.04% of the portfolio, ranked #135.
Davis Capital Management first reported a position in LLY in Q1 2020 and has held it in 12 quarters since. The position peaked at $103K in Q3 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Davis Capital Management held 61 shares of Eli Lilly worth $73.2K as of Q2 2026.
- Davis Capital Management bought 48 Eli Lilly shares in Q2 2026, an estimated $49K.
- Eli Lilly made up 0.04% of Davis Capital Management's portfolio in Q2 2026, its #135 holding.
- Davis Capital Management first reported a position in Eli Lilly in Q1 2020 and has held it in 12 quarters since.
- Davis Capital Management's Eli Lilly position peaked at $103K in Q3 2024.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.